Andrew Donald Clouston

Andrew Donald Clouston

Auto-generated profile, based on publicly available information

Andrew Donald Clouston

Envoi Specialist Pathologists, Brisbane, Qld, Australia

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2015 in JAMA
Verified
Journal Article
Open access
PDF file
ASAndrew R. L. Stevenson
Andrew R. L. Stevenson
MSMichael J Solomon
Michael J Solomon
JLJohn W. Lumley
John W. Lumley
PHPeter Hewett
Peter Hewett
ACAndrew D. Clouston
Andrew D. Clouston
JSJohn Simes
John Simes
Importance: Laparoscopic procedures are generally thought to have better outcomes than open procedures. Because of anatomical constraints, laparoscopic rectal resection may not be better because of limitations in performing an adequate cancer resection. Objective: To determine whether laparoscopic resection is noninferior to open rectal cancer resection for adequacy of cancer clearance. Design, setting, and participants: Randomized, noninferiority, phase 3 trial (Australasian Laparoscopic Cancer of the Rectum; ALaCaRT) conducted between March 2010 and November 2014. Twenty-six accredited surgeons from 24 sites in Australia and New Zealand randomized 475 patients with T1-T3 rectal adenocarcinoma less than 15 cm from the anal verge. Interventions: Open laparotomy and rectal resection (n = 237) or laparoscopic rectal resection (n = 238). Main outcomes and measures: The primary end point was a composite of oncological factors indicating an adequate surgical resection, with a noninferiority boundary of Δ = -8%. Successful resection was defined as meeting all the following criteria: (1) complete total mesorectal excision, (2) a clear circumferential margin (≥1 mm), and (3) a clear distal resection margin (≥1 mm). Pathologists used standardized reporting and were blinded to the method of surgery. Results: A successful resection was achieved in 194 patients (82%) in the laparoscopic surgery group and 208 patients (89%) in the open surgery group (risk difference of -7.0% [95% CI, -12.4% to ∞]; P = .38 for noninferiority). The circumferential resection margin was clear in 222 patients (93%) in the laparoscopic surgery group and in 228 patients (97%) in the open surgery group (risk difference of -3.7% [95% CI, -7.6% to 0.1%]; P = .06), the distal margin was clear in 236 patients (99%) in the laparoscopic surgery group and in 234 patients (99%) in the open surgery group (risk difference of -0.4% [95% CI, -1.8% to 1.0%]; P = .67), and total mesorectal excision was complete in 206 patients (87%) in the laparoscopic surgery group and 216 patients (92%) in the open surgery group (risk difference of -5.4% [95% CI, -10.9% to 0.2%]; P = .06). The conversion rate from laparoscopic to open surgery was 9%. Conclusions and relevance: Among patients with T1-T3 rectal tumors, noninferiority of laparoscopic surgery compared with open surgery for successful resection was not established. Although the overall quality of surgery was high, these findings do not provide sufficient evidence for the routine use of laparoscopic surgery. Longer follow-up of recurrence and survival is currently being acquired. Trial registration: anzctr.org Identifier: ACTRN12609000663257.

1 April 1999 in Hepatology
Verified
Journal Article
Open access
PDF file
LHLuke F. Hourigan
Luke F. Hourigan
Graeme MacdonaldGraeme Macdonald
Graeme Macdonald
DPDavid Purdie
David Purdie
VWVicki H. Whitehall
Vicki H. Whitehall
CSClaudia Shorthouse
Claudia Shorthouse
EPElizabeth E. Powell
Elizabeth E. Powell
Steatosis is a frequent histological finding in chronic hepatitis C infection; however, the pathophysiology of steatosis and its role in disease progression have not been established. We studied 148 consecutive patients with untreated chronic hepatitis C to assess the effect of body mass index, diabetes mellitus, alcohol consumption, hepatic iron content, and viral load on steatosis and hepatic fibrosis. Ninety–one patients (61%) had steatosis: grade 1 (70% hepatocytes involved) in 13 (9%). After adjusting for potential confounding variables, a highly significant relationship was found primarily between steatosis and body mass index (P < .0001). The mean (±SD) body mass index of patients with no steatosis was 23.9 ± 4.3 kg/m2, whereas for grade 1 steatosis it was 26.5 ± 5.1 kg/m2, and for grade 2 and 3 steatosis combined the body mass index was 28.4 ± 4.9 kg/m2. Hepatic fibrosis was significantly associated with age (P = .002). After adjusting for potential confounding variables, including age, hepatic fibrosis was also significantly associated with steatosis (P < .03). There was no significant association between hepatic iron content, alcohol intake, gender, and viral load and steatosis or fibrosis. These findings suggest that increasing body mass index has a role in the pathogenesis of steatosis in chronic hepatitis C and that steatosis may contribute to fibrosis. The association between body mass index and steatosis and fibrosis has important prognostic and therapeutic implications in the management of patients with chronic hepatitis C virus

11 November 2010 in Blood
Verified
Journal Article
Closed access
PDF file
KMKelli P. A. MacDonald
Kelli P. A. MacDonald
JPJames S. Palmer
James S. Palmer
SCStephen Cronau
Stephen Cronau
ESElke Seppanen
Elke Seppanen
SOStuart Olver
Stuart Olver
DHDavid A. Hume
David A. Hume
The development of the mononuclear phagocyte system requires macrophage colony-stimulating factor (CSF-1) signaling through the CSF-1 receptor (CSF1R, CD115). We examined the effect of an antibody against CSF1R on macrophage homeostasis and function using the MacGreen transgenic mouse (csf1r-enhanced green fluorescent protein) as a reporter. The administration of a novel CSF1R blocking antibody selectively reduced the CD115+Gr-1neg monocyte precursor of resident tissue macrophages. CD115+Gr-1+ inflammatory monocytes were correspondingly increased, supporting the view that monocytes are a developmental series. Within tissue, the antibody almost completely depleted resident macrophage populations in the peritoneum, gastrointestinal tract, liver, kidney, and skin, but not in the lung or female reproductive organs. CSF1R blockade reduced the numbers of tumor-associated macrophages in syngeneic tumor models, suggesting that these cells are resident type macrophages. Conversely, it had no effect on inflammatory monocyte recruitment in models, including lipopolysaccharide-induced lung inflammation, wound healing, peritonitis, and severe acute graft-versus-host disease. Depletion of resident tissue macrophages from bone marrow transplantation recipients actually resulted in accelerated pathology and exaggerated donor T-cell activation. The data indicate that CSF1R signaling is required only for the maturation and replacement of resident-type monocytes and tissue macrophages, and is not required for monocyte production or inflammatory function.

22 January 2013 in Histopathology
Verified
Journal Article
Closed access
PDF file
MBMark Bettington
Mark Bettington
NWNeal Walker
Neal Walker
ACAndrew Clouston
Andrew Clouston
IBIan Brown
Ian Brown
BLBarbara Leggett
Barbara Leggett
VWVicki Whitehall
Vicki Whitehall

1 April 2014 in Hepatology
Verified
Journal Article
Closed access
PDF file
VGVictoria L. Gadd
Victoria L. Gadd
RSRichard Skoien
Richard Skoien
EPElizabeth E. Powell
Elizabeth E. Powell
KFKevin J. Fagan
Kevin J. Fagan
CWClay Winterford
Clay Winterford
ACAndrew D. Clouston
Andrew D. Clouston

1 July 2007 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
MRMichelle M. Richardson
Michelle M. Richardson
JJJulie R. Jonsson
Julie R. Jonsson
EPElizabeth E. Powell
Elizabeth E. Powell
EBElizabeth M. Brunt
Elizabeth M. Brunt
BNBrent A. Neuschwander–Tetri
Brent A. Neuschwander–Tetri
ACAndrew D. Clouston
Andrew D. Clouston